Dr. Rajiv Pathak is an accomplished virologist whose academic journey began with an M.Sc. from the University of Lucknow (2007–2009), followed by a Ph.D. at the CSIR-Institute of Genomics & Integrative Biology, Delhi (2010–2016). He continued his scientific pursuits with a postdoctoral fellowship at the Department of Genetics, Albert Einstein College of Medicine, New York, USA (2017–2022), where he currently serves as a staff scientist (2022-Present). Dr. Pathak has contributed significantly to multiple interdisciplinary projects aimed at advancing therapeutic strategies and addressing key challenges in infectious disease research. His work spans a wide spectrum, including the functional relevance of G-quadruplexes in microorganisms, the development of novel therapeutic approaches against multidrug-resistant bacteria, HIV-1 latency and persistence, early replication kinetics of SARS-CoV-2, and the molecular pathogenesis of SMARCB1-associated atypical teratoid/rhabdoid tumors (a rare pediatric cancer). He has authored over 33 peer-reviewed publications in high-impact journals such as Nucleic Acids Research, Acta Neuropathologica, and Nature Communications. His commitment and dedication to scientific advancement are further demonstrated by his active involvement in the scientific societies, where he has served as an editorial board member for 6 journals and reviewed over 60 manuscripts for more than 20 well-reputed journals in the field.